iiinova — where your digital self keeps evolving

Bojmar's lab @bojmarlab.bsky.social · 26/03/2026

Where will we be seeing Aidita in the future? She hasn't yet decided what medical specialty she wants to pursue in the future, but surgery has definitely sparked her interest! #CancerResearch #ColonCancer #TranslationalResearch

000

Bojmar's lab @bojmarlab.bsky.social · 26/03/2026

She has a strong interest in cancer research and finds it especially exciting when experimental findings can be connected to clinical practice. She finds it very rewarding to study cancer from both a research and clinical perspective.

100

Bojmar's lab @bojmarlab.bsky.social · 26/03/2026

🧫 🩺 Meet Ardita Medical student, currently conducting her thesis work at the Bojmar lab. Her project focuses on extracellular vesicles and hepatic IBA1 expression in relation to colon cancer progression.

100

Bojmar's lab @bojmarlab.bsky.social · 19/11/2025

These grants will help us push the boundaries of cancer research and better understand metastatic processes, always with patients as our #1 priority. Thank you for believing in our science and our vision!! #LiU #CancerResearch

010

Bojmar's lab @bojmarlab.bsky.social · 19/11/2025

“Multimodal analysis of systemic effects in gastrointestinal cancer for relapse prediction and individualized treatment – focusing on extracellular vesicles and pre-metastatic niches.” and "From organ to whole body: scaling up ex vivo cancer metabolism with digital twins.”

110

Bojmar's lab @bojmarlab.bsky.social · 19/11/2025

Feeling incredibly grateful to @vetenskapsradet.bsky.social for supporting our research at @liu.se with grants for two of our exciting projects:

121

Bojmar's lab @bojmarlab.bsky.social · 18/11/2025

In other words, from pre-metastatic niche formation to overt metastasis. A key aim of his work is to translate these biological insights into improved strategies for the prevention and treatment of recurrence. #CancerResearch #Metastasis #TranslationalResearch

010

Bojmar's lab @bojmarlab.bsky.social · 18/11/2025

🧫 🩺 Meet Chuanwen Fan He researches the mechanisms driving therapy resistance and metastasis in gastrointestinal cancers, focusing particularly on how stemness- and plasticity-associated cancer cell states and the primary tumor secretome, including tumor EVs, shape metastatic progression.

110

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

His passion for pancreatic cancer began in clinical work, and now continues his research at the Department of Clinical Pathology, Linköping University Hospital. Off‑lab, he loves hiking and climbing. #PancreaticCancer #Pathology

010

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🧫 🩺 Meet Håkon Andersen Blomstrand Pathologist, MD PhD Originally from Uppsala, Håkon earned his medical degree at Gothenburg in 2013 and his PhD last year at Linköping's University.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

She joined the Bojmar group in 2022 and leads the collection and processing of patient materials: essential to projects on EV biomarkers and the pre‑metastatic niche. Outside of work, she enjoys kayaking, gardening and arts. #ResearchEngineer #Premetastatic #Biomaterials #CancerResearch

010

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🧬 Meet Carolin Jönsson Research Engineer Born in southern Germany, Carolin trained at the Max‑Planck Institute and later worked in Switzerland and Toronto before moving to Sweden in 1993.

110

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

He emphasizes the power of large collaborative networks to address clinical challenges and integrates closely with the Bojmar Lab’s translational work. #SurgicalOncology #TranslationalResearch #HPBsurgery

000

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Bergthor Björnsson MD, PhD, Docent / Senior Consultant Bergthor’s clinical and translational research centers on pancreatic and liver surgery—he has led randomized and multicenter trials at Linköping.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

He has led extensive clinical, registry-based, and international studies to improve diagnostics, evaluate therapies, and optimize patient selection. #HPBCancer #PancreaticCancer #HepatobiliarySurgery #ClinicalResearch #TranslationalResearch

000

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Per Sandström Adjungerad professor, MD/PhD Per’s research focuses on patients with liver, biliary tract, and pancreatic tumors, striving to refine the boundaries between treatment options and ensure equal access to assessment and care for all patients.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

His research integrates stable isotope tracing, mass spectrometry, and systems biology to increase translational relevance while reducing animal use. #CancerMetabolism #SystemsBiology #TranslationalResearch #MetabolicReprogramming

010

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🧬 Meet Mohamed Elhusseiny Post-doc Researcher His work centers on cancer metabolism and metabolic reprogramming, with a focus on developing ex vivo and computational models to better understand tumor–host interactions.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

With deep expertise in protein chemistry, biophysics and EV technology, he now drives method development, managing key EV instruments, expanding isolation pipelines, and leading the local EV network at LiU. #EVResearch #CancerMetastasis #PreMetastaticNiche

000

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🔬 Meet Alexander Sandberg PhD, Principal Research Engineer During his PhD he investigated amyloid-forming proteins in neurodegenerative disease. Since 2024, he has been part of Bojmar’s group, focusing on how EV’s shape the pre-metastatic niche in GI cancers.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

She works clinically in pediatric oncology and within the Bojmar group she studies cancer‑derived extracellular vesicles and the immunological aspect of the pre-metastatic niche. #PediatricOncology #CancerResearch

010

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Paulina Velasco Riestra MD Paulina earned her MD in Mexico City and began her research career at MD Anderson in pulmonary medicine.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

Now he focuses on immune‑mediated mechanisms, radiomic/molecular profiling, and personalized treatment tailoring. #SurgeonScientist #PancreaticCancer #PrecisionOncology

000

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Constantinos Zambirinis MD, MRes Originally from Paphos, Cyprus. He completed surgical training and oncology fellowships across the U.S., and spent time at NYU and Memorial Sloan Kettering studying inflammation’s role in pancreatic cancer and the liver pre‑metastatic niche.

100

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

She joined the Bojmar group in fall 2024 to study portal biomarkers in gastrointestinal cancers, particularly pancreatic cancer, and their clinical applications. #SurgeontoBe #PortalBiomarkers #ResearchJourney

000

Bojmar's lab @bojmarlab.bsky.social · 14/11/2025

🩺 Meet Verena Unterkircher MD Raised in a small Alpine town in Northern Italy, Verena graduated from Medical University of Innsbruck in 2024, where she engaged in vascular surgery research and teaching.

100

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

He’s now surgical consultant and PhD investigating risk factors and outcomes of colorectal cancer in younger patients. His collaboration with the Bojmar Lab began in 2022. #ColorectalCancer #SurgicalOncology #ClinicalResearch

000

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🩺 Meet Erik Lundqvist MD, Surgical Consultant, PhD. A native of Söderköping, Erik studied medicine at Linköping. The overall aim with his research is to improve the diagnosis and management of patients with colorectal cancer, affecting almost 7000 new individuals in Sweden each year.

120

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

After working in Reykjavik, she’s now back in Linköping, contributing to clinical data collection for upcoming projects in the Bojmar group. #PancreasSurgery #ClinicalResearch #SurgicalOncology

000

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🩺️ Meet Karin Johansen MD, PhD From Gothenburg, Karin graduated from Linköping’s medical school in 2018. Her PhD was in pancreatic surgery, cost‑effectiveness, and quality of life.

110

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

Under Linda Bojmar’s supervision, he’s investigating molecular markers that influence radiotherapy response in colorectal cancer, focusing on extracellular vesicle cargo and the establishment of pre‑metastatic niches. #ColorectalCancer #PhDLife #EVresearch

000

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🔬 Meet Jonas Burman PhD candidate Raised in Karlstad, Jonas moved to Linköping for his bachelor's in biology and later completed a master’s in Experimental & Medical Biosciences in 2022. He did an international exchange in the Lyden lab, at Weill Cornell Medicine in New York.

100

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

After earning her master’s in medicine at Linköping, she joined Linda Bojmar’s team in April 2023 to study cancer‑derived extracellular vesicles—their role in progression and potential as biomarkers. #Oncology #EVResearch #PhDLife

000

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🩺 Meet Elena Arlaman MD, PhD candidate Elena was born and raised from Syria and studied pharmacy at Damascus University before relocating to Sweden in 2014, and completing MD training at Linköping University. She's currently an oncology resident and researcher.

100

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

She co‑led early studies on the hepatic pre‑metastatic niche in pancreatic cancer patients, now heading a translational research lab in Sweden working across disciplines. When not bridging hospital and lab, she enjoys being outdoors with family and horses. #CancerResearch #EVBiomarkers #TeamLead

000

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

🧪 Meet Linda Bojmar PhD, Assistant Professor, Docent Linda trained in Linköping and completed her post‑doc at Weill Cornell, focusing on extracellular vesicles and cancer progression.

100

Reposted by Bojmar's lab

Linköping University @liu.se · 04/09/2025

Cancer researcher Linda Bojmar at Linköping University has been awarded a Starting Grant from @erc.europa.eu to study how pancreatic #cancer spreads — and how treatment can be tailored to each patient. #AcademicSky 🧪 liu.se/en/news-item/erc-starting-grant-till-linda-bojmar

liu.se

ERC Starting Grant to Linda Bojmar

Linda Bojmar has been awarded just over SEK 16 million from the European Research Council, ERC. Her research aims to increase understanding of how pancreatic cancer spreads in the body and how treatme...

072

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

Huge congratulations to our PI Linda Bojmar for leading this dream project and to all the new grantees shaping the future of science!

000

Bojmar's lab @bojmarlab.bsky.social · 05/09/2025

Yesterday the @erc.europa.eu announced the 2025 Starting Grant winners. We’re beyond thrilled and grateful that our project SYST-E-MET: Systemic Effects on Metastasis – a look beyond the tumor was selected for funding!

120

Reposted by Bojmar's lab

Let's Win Pancreatic Cancer @letswinpc.org · 23/06/2025

The 2025 ASCO meeting featured research on pancreatic cancer, including a new treatment modality and a novel treatment combination. bit.ly/43VHWOL #OncoSky

bit.ly

Pancreatic Cancer Research Highlights from ASCO Annual Meeting

The 2025 ASCO meeting featured pancreatic cancer research including a new treatment modality and a new treatment combination.

021

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

This work is the result of a great international collaboration! Huge thanks to Darrell Green and Emma Bull for bringing together such a strong multidisciplinary team. Check out our review on paediatric bone sarcomas #PaedsOnc #SarcomaResearch molecular-cancer.biomedcentral.com/articles/10....

molecular-cancer.biomedcentral.com

Targeting metastasis in paediatric bone sarcomas - Molecular Cancer

Paediatric bone sarcomas (e.g. Ewing sarcoma, osteosarcoma) comprise significant biological and clinical heterogeneity. This extreme heterogeneity affects response to systemic therapy, facilitates inh...

031

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

We are a part of the #FOSTER consortium (Fight OsteoSarcoma Through European Research). It proposes to connect multidisciplinary and patient/parent advocate expertise, at a Pan-European level to improve biological, translational and clinical research on #osteosarcoma to ultimately improve survival.

010

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

It was incredibly motivating to see the impact of collaborative, patient-centered science. An honor to be part of LiU’s first year at #SCRM. We’re already looking forward to continuing our research and sharing new findings at next year’s meeting!

000

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

We also had the chance to hear @juditarvelund.bsky.social, inspiring PI and collaborator from @liu.se, present her work on oncolytic virus-based #immunotherapy for lymphoma, highlighting the powerful role of dendritic cells. (Check her profile to read more about her work!)

210

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

From our lab, Linda presented a talk on the hepatic #preMetastatic niche in #pancreaticcancer and how systemic effects of cancer may serve as biomarkers for metastasis. Meanwhile, Mohamed, @jonasburman.bsky.social, and Verena contributed with poster presentations showcasing their exciting work!

110

Bojmar's lab @bojmarlab.bsky.social · 24/06/2025

This year was the 7th Swedish Cancer Research Meeting #SCRM and for the first time @liu.se @liucancer.bsky.social took part in the national programme committee. A big thanks to Lund University Cancer Centre @lunduniversity.bsky.social for hosting this year’s gathering! This is our lab's insight:

131

Reposted by Bojmar's lab

Metastasis Research Society @metastasisresearch.bsky.social · 31/12/2024

6/Timing of pancreas cancer metastasis. By profiling patient samples, the authors reveal immune remodeling in the pre-metastatic liver and propose liver sampling to determine pancreas cancer metastatic propensity. David Lyden Weill Cornell www.nature.com/articles/s41...

nature.com

Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer - Nature Medicine

A multi-modal analysis of pre-metastatic liver biopsies from patients with localized pancreatic cancer with a minimum of 3 years of follow-up shows that immunological, proliferative and metabolomic fe...

162

Bojmar's lab @bojmarlab.bsky.social · 18/06/2025

Unlike normal cells, cancer cells can't convert homocysteine due to low MTR enzyme activity. We will investigate whether this methionine dependency is also present in patient tissue. If confirmed, adjusting homocysteine levels could help slow tumor growth without harming normal cells.

100